Enveric Biosciences Stock Slips as Cash Questions Hang Over ENVB
Enveric Biosciences shares fell Friday, with the stock hanging near recent lows. The small-cap biotech had little news, and investors are watching for progress with its main drug candidate before human trials. The stock closed at $2.30 on Nasdaq, slipping 0.86%. Shares traded in a range of $2.20 to $2.41. Market cap stood near $8.47 million. The 52-week span is $1.71 to $17.64, showing the wide swings in the stock.